Stockscreener 앱 받기
19.85
6.76%
-1.37
전일 마감가:
$21.22
열려 있는:
$20.95
하루 거래량:
729.12K
Relative Volume:
0.57
시가총액:
$2.72B
수익:
$2.89B
순이익/손실:
$-33.80M
주가수익비율:
-73.52
EPS:
-0.27
순현금흐름:
$204.10M
1주 성능:
-7.20%
1개월 성능:
-18.28%
6개월 성능:
-37.94%
1년 성능:
-16.97%
1일 변동 폭
$19.75
$21.05
1주일 범위
$19.76
$21.59
52주 변동 폭
$19.50
$33.97
Surgery Partners Inc Stock (SGRY) Company Profile
명칭
Surgery Partners Inc
전화
615-234-5900
주소
310 SEVEN SPRINGS WAY, BRENTWOOD, TN
SGRY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
19.84 | 2.72B | 2.89B | -33.80M | 204.10M | -0.27 |
|
HCA
Hca Healthcare Inc
|
316.74 | 83.86B | 70.60B | 5.76B | 5.64B | 21.97 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.34 | 14.48B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
DVA
Davita Inc
|
133.75 | 12.28B | 12.67B | 827.68M | 1.42B | 9.27 |
|
THC
Tenet Healthcare Corp
|
110.50 | 11.90B | 20.97B | 3.13B | 2.39B | 31.21 |
|
UHS
Universal Health Services Inc
|
155.53 | 11.66B | 15.42B | 1.03B | 956.84M | 15.02 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-16 | 개시 | BofA Securities | Buy |
| 2024-10-14 | 개시 | UBS | Buy |
| 2024-10-11 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2024-06-28 | 개시 | Macquarie | Outperform |
| 2024-03-06 | 개시 | Barclays | Equal Weight |
| 2023-11-14 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-06-02 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-05-12 | 개시 | Mizuho | Buy |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-11-23 | 재확인 | RBC Capital Mkts | Outperform |
| 2022-06-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-01-10 | 재개 | Citigroup | Buy |
| 2021-11-30 | 개시 | Barclays | Overweight |
| 2021-11-29 | 업그레이드 | Stifel | Hold → Buy |
| 2021-11-01 | 개시 | JP Morgan | Neutral |
| 2021-10-18 | 개시 | SVB Leerink | Outperform |
| 2021-09-10 | 개시 | Cowen | Market Perform |
| 2021-06-23 | 재개 | Stifel | Hold |
| 2020-09-17 | 재확인 | The Benchmark Company | Buy |
| 2020-04-27 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2020-03-03 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2020-01-14 | 재확인 | The Benchmark Company | Buy |
| 2018-11-16 | 개시 | UBS | Neutral |
| 2018-09-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2018-06-28 | 업그레이드 | Stifel | Sell → Hold |
| 2018-01-30 | 재확인 | The Benchmark Company | Buy |
| 2017-11-01 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-08-09 | 다운그레이드 | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-08-09 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2017-08-09 | 다운그레이드 | Stifel | Hold → Sell |
| 2017-04-24 | 재확인 | Stifel | Hold |
| 2017-03-10 | 다운그레이드 | Stifel | Buy → Hold |
| 2017-01-31 | 개시 | The Benchmark Company | Buy |
| 2016-06-10 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2016-03-14 | 재확인 | RBC Capital Mkts | Outperform |
| 2015-10-27 | 개시 | Stifel | Buy |
| 2015-10-26 | 개시 | RBC Capital Mkts | Outperform |
| 2015-10-26 | 개시 | Raymond James | Strong Buy |
모두보기
Surgery Partners Inc 주식(SGRY)의 최신 뉴스
Surgery Partners, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call Details | SGRY Stock News - GuruFocus
Surgery Partners, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call Details - TradingView
Surgery Partners Sets Q1 2025 Earnings Date: Key Financial Updates Coming May 12 - Stock Titan
Oral Surgery Partners Signs 4,930 SF Lease in Clinton Township, Michigan - REBusinessOnline
USDollar Is Moving As Anticipated In 2025 - The Globe and Mail
America's Best Ambulatory Surgery Centers 2024 - Newsweek
3 Reasons SGRY is Risky and 1 Stock to Buy Instead - Yahoo Finance
Cantor Fitzgerald maintains Overweight on Surgery Partners stock at $36 target - Investing.com Canada
Cantor Fitzgerald maintains Overweight on Surgery Partners stock at $36 target By Investing.com - Investing.com South Africa
Clearbridge Investments LLC Sells 266,519 Shares of Surgery Partners, Inc. (NASDAQ:SGRY) - MarketBeat
Rock Tech's designation as "Strategic Project" by the European Commission is considered a "Transformational Milestone"Only three Lithium projects in Germany were selectedRock Tech is the only full-scale European Lithium refinery using proven and - The Globe and Mail
Surgery Partners jumps on $25.75 a share offer from Bain Capital (update) - MSN
Palantir Setting Up to Be a Big Winner With New Defense Spending - The Globe and Mail
Quantum and AI Disruption Is Creating a New Class of Must-Watch Tech Stocks - The Globe and Mail
Ambulatory Surgical Centers Market: Transforming Outpatient - openPR.com
Surgery Partners Inc (SGRY) Stock Price Down 5.48% on Jan 14 - GuruFocus.com
Surgery Partners’ chief strategy officer Marissa Brittenham sells $76,028 in stock - Investing.com India
U.S. Ambulatory Surgery Center Market Set to Witness Significant Growth by 2025-2032: AmSurg Corp., Surgery - EIN News
Surgery Partners (NASDAQ:SGRY) Price Target Lowered to $33.00 at Macquarie - Defense World
(SGRY) Trading Report - Stock Traders Daily
Macquarie Trims Price Target on Surgery Partners to $33 From $34, Keeps Outperform Rating - Marketscreener.com
Earnings call transcript: Surgery Partners Inc Q4 2024 beats forecasts By Investing.com - Investing.com Australia
Surgery Partners, Inc. SEC 10-K Report - TradingView
Surgery Partners, Inc. to Host Earnings Call - ACCESS Newswire
Surgery Partners, Inc. (NASDAQ:SGRY) Q4 2024 Earnings Call Transcript - MSN
Surgery Partners (SGRY) Q4 Earnings and Revenues Surpass Estimates - MSN
Surgery Partners to Acquire National Surgical Healthcare from Irving Place Capital - Bain Capital
Why Surgery Partners’ Stock Is Facing Turbulence - TipRanks
Surgery Partners: Strong Growth and Strategic Positioning Drive Buy Rating - TipRanks
Surgery Partners Delays Annual Report Filing - TipRanks
Surgery Partners stock price target cut to $35 by Benchmark - Investing.com India
UBS cuts Surgery Partners stock target to $34, maintains Buy rating - Investing.com India
KeyBanc maintains Sector Weight on Surgery Partners stock - Investing.com India
UBS cuts Surgery Partners stock target to $34, maintains Buy rating By Investing.com - Investing.com South Africa
KeyBanc maintains Sector Weight on Surgery Partners stock By Investing.com - Investing.com UK
UBS Cuts Price Target on Surgery Partners to $34 From $38, Keeps Buy Rating -March 04, 2025 at 08:55 am EST - Marketscreener.com
Surgery Partners price target lowered to $35 from $40 at Benchmark - TipRanks
Surgery Partners Inc (SGRY) Q4 2024 Earnings Call Highlights: Re - GuruFocus.com
Surgery Partners Inc (SGRY) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Expansion - Yahoo Finance
Surgery Partners outlines 2025 guidance with $3.3B-$3.45B revenue target, driven by high acuity growth - MSN
Surgery Partners Reports Strong Revenue Growth for 2024 - TipRanks
Surgery Partners Inc. Reports Record Growth in Earnings Call - TipRanks
Earnings call transcript: Surgery Partners Inc Q4 2024 beats forecasts - Investing.com India
Healthcare Companies Excel In Q1 2024 Earnings Reports - Evrim Ağacı
Surgery Partners Surges on Strong Q4 Results and Bain Capital Pr - GuruFocus.com
Surgery Partners: Q4 Earnings Snapshot - mySA
Surgery Partners Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Surgery Partners Inc (SGRY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.34%
0.67%
자본화:
|
볼륨(24시간):